The most widespread misunderstanding in neuroscience
The popular story: dopamine = pleasure. The neuroscience: dopamine signals reward prediction and prediction error, not pleasure itself. This distinction, established by Wolfram Schultz's landmark experiments in the 1990s, revolutionized our understanding of motivation and addiction.
Structure: a catecholamine
Dopamine (3,4-dihydroxyphenylethylamine, C₈H₁₁NO₂) is a catecholamine — a phenylethylamine with two hydroxyl groups at positions 3 and 4 of the aromatic ring (the catechol group). Synthesized from L-tyrosine in two steps (tyrosine hydroxylase → DOPA decarboxylase). It is also the precursor to noradrenaline and adrenaline.
The four dopaminergic pathways
Mesolimbic (VTA → nucleus accumbens): the "reward pathway." Implicated in addiction (hyperactivity) and anhedonic depression (hypoactivity). Mesocortical (VTA → prefrontal cortex): working memory, planning, impulse control. Its deficit is the core of ADHD — why stimulants (methylphenidate) that increase cortical dopamine improve focus. Nigrostriatal (substantia nigra → striatum): voluntary movement. Degeneration of this pathway causes Parkinson's disease (>60% neuron loss → tremor, rigidity, bradykinesia). Tuberoinfundibular (hypothalamus → pituitary): inhibits prolactin. Antipsychotics blocking dopamine receptors elevate prolactin as a side effect.
The prediction error: dopamine's true function
Schultz's experiment: dopamine neurons fired strongly at unexpected juice reward. After conditioning (tone preceding juice), neurons stopped firing at the juice and started firing at the tone. If the tone sounded but the juice didn't arrive, activity dropped below baseline. Dopamine encodes reward prediction error (RPE): unexpected reward → spike; expected reward → no change; expected reward missing → dip below baseline.
Addiction: a hijacking of the prediction signal
Drugs of abuse each produce massive dopamine surges in the nucleus accumbens through different mechanisms: cocaine (blocks DAT reuptake transporter), amphetamines (reverse DAT, forcing active dopamine release), nicotine (activates nicotinic receptors on dopaminergic neurons), opioids (disinhibit dopaminergic neurons by blocking inhibitory GABAergic interneurons). With repeated use, the brain downregulates D2 receptors and reduces baseline dopamine, creating tolerance and anhedonic withdrawal.